Patent Holder
Yosef Refaeli
US Patent N. 5780238 - VPR receptor protein
US Patent N. 6667157 - Methods and compositions to abrogate cellular proliferation
US PAtent N. 6838236 - VPR function and activity
US Patent N. 5780220 - Methods and compositions for inhibiting HIV replication
US Patent N. 5639598 - Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US Patent N. 5763190 - Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein
US Patent N. 6667157 - Methods and compositions to abrogate cellular proliferation
US PAtent N. 6838236 - VPR function and activity
US Patent N. 5780220 - Methods and compositions for inhibiting HIV replication
US Patent N. 5639598 - Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US Patent N. 5763190 - Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein